Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2918-2928

  Stanojevic, Violeta ^a,b   Habener, Joel F ^a,b,c   Thomas, Melissa K ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P300; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PDX 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CARCINOMA CELL; DNA BINDING; FEMALE; GENE EXPRESSION; GENE MUTATION; GLUCOSE HOMEOSTASIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; UTERINE CERVIX CARCINOMA;

ANIMALS; CELL LINE; DIABETES MELLITUS, TYPE 2; E1A-ASSOCIATED P300 PROTEIN; HOMEODOMAIN PROTEINS; HUMANS; MUTATION; NUCLEAR PROTEINS; POINT MUTATION; RATS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 2542430265     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1188     Document Type: Article

References (39)

1. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BLM, Wright CVE 1996 PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995
2. Miller CP, McGehee RE, Habener JF 1994 IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13:1145-1156
3. Ohlsson H, Karlsson K, Edlund T 1993 IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 12:4251-4259
4. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, Montminy MR 1993 Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 7:1275-1283
5. Jonsson J, Carlsson L, Edlund T, Edlund H 1994 Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-609
6. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF 1997 Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 coding region. Nat Genet 15:106-110
7. German MS, Wang J, Chadwick RB, Rutter WJ 1992 Synergistic activation of the insulin gene by a LIM-homeodomain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev 6:2165-2176
8. Petersen HV, Serup P, Leonard J, Michelsen BK, Madsen OD 1994 Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through CT boxes. Proc Natl Acad Sci USA 91:10465-10469
9. Melloul D, Ben-Neriah Y, Cerasi E 1993 Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci USA 90:3865-3869
10. Marshak S, Totary H, Cerasi E, Melloul D 1996 Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA 93:15057-15062
11. Johnson JD, Zhang W, Rudnick A, Rutter WJ, German MS 1997 Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the L1M2 domain determines specificity. Mol Cell Biol 17:3488-3496
12. Ohneda K, Mirmira RG, Wang J, Johnson JD, German MS 2000 The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol 20:900-911
13. Asahara H, Dutta S, Kao HY, Evans RM, Montminy M 1999 Pbx-Hox heterodimers recruit coactivator-corepressor complexes in a isoform-specific manner. Mol Cell Biol 19:8219-8225
14. Qiu Y, Sharma A, Stein R 1998 p300 Mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol Cell Biol 18:2957-2964
15. Thomas MK, Yao KM, Tenser MS, Wong GG, Habener JF 1999 Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription. Mol Cell Biol 19:8492-8504
16. Qiu Y, Guo M, Huang S, Stein R 2002 Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol 22:412-420
17. Stoffers DA, Ferrer J, Clarke WL, Habener JF 1997 Early-onset type-11 diabetes mellitus (MODY4) linked to IPF-1. Nat Genet 17:138-139
18. Hani EH, Stoffers DA, Chevre JC, Durand E, Stanojevic V, Dina C, Habener JF, Froguel P 1999 Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 104:R41-R48
19. Macfarlane WM, Frayling TM, Ellard S, Evans JC, Alien LI, Bulman MP, Ayres S, Shepherd M, Clark P, Millward A, Demaine A, Wilkin T, Docherty K, Hattersley AT 1999 Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 104:R33-R39
20. Weng J, Macfarlane WM, Lehto M, Gu HF, Shepherd LM, Ivarsson SA, Wibell L, Smith T, Groop LC 2001 Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 44:249-258
21. Weng J, Ekelund M, Lehto M, Li H, Ekberg G, Frid A, Aberg A, Groop LC, Berntorp K 2002 Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25:68-71
22. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H 1998 β-Cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev 12:1763-1768
23. Dutta S, Bonner-Weir S, Montminy M, Wright C 1998 Regulatory factor linked to late-onset diabetes? Nature 392:560
24. Brissova M, Shiota M, Nicholson WE, Cannon M, Knobel SM, Piston DW, Wright CV, Powers AC 2002 Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232
25. Thomas MK, Devon ON, Lee JH, Peter A, Schlosser DA, Tenser MS, Habener JF 2001 Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 108:319-329
26. Holland AM, Hale MA, Kagami H, Hammer RE, MacDonald RJ 2002 Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci USA 99:12236-12241
27. Hansen L, Urioste S, Petersen HV, Jensen JN, Eiberg H, Barbetti F, Setup P, Hansen T, Pedersen O 2000 Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians. J Clin Endocrinol Metab 85:1323-1326
28. Stoffers DA, Stanojevic V, Habener JF 1998 Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 102:232-241
29. Thomas MK, Rastalsky N, Lee JH, Habener JF 2000 Hedgehog signaling regulates insulin production by pancreatic β-cells. Diabetes 49:2039-2047
30. Thomas MK, Lee JH, Rastalsky N, Habener JF 2001 Hedgehog signaling regulation of homeodomain protein IDX-1 expression in pancreatic β cells. Endocrinol 142:1033-1040
31. Peers B, Leonard J, Sharma S, Teitelman G, Montminy MR 1994 Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol 8:1798-1806
32. Stein RW, Whelan J 1989 Insulin gene enhancer activity is inhibited by adenovirus 5 E1a gene products. Mol Cell Biol 9:4531-4534
33. Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E 1990 Analysis of E1A-mediated growth regulation functions: binding of the 300-kildalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J Virol 64:4421-4427
34. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM 1996 Role of CBP/p300 in nuclear receptor signaling. Nature 383:99-103
35. Thomas MK, Habener JF 2004 IDX1 and pancreatic agenesis and type 2 diabetes. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. Inborn errors of development: the molecular basis of clinical disorders of morphogenesis. Oxford, UK: Oxford University Press; 552-556
36. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
37. Andreassen OA, Dedeoglu A, Stanojevic V, Hughes DB, Browne SE, Leech CA, Ferrante RJ, Habener JF, Beal MF, Thomas MK 2002 Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 11:410-424
38. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS 1999 Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328
39. Eeckhoute J, Formstecher P, Laine B 2001 Maturity-onset diabetes of the young type 1 (MODY1)-associated mutations R154X and E276Q in hepatocyte nuclear factor 4alpha (HNF4α) gene impair recruitment of p300, a key transcriptional coactivator. Mol Endocrinol 15:1200-1210